The Development and Evaluation of an "E-Visit" Program for the Management of Acne

Not Applicable

Completed

• Conditions: Acne Vulgaris
• Interventions: Other: Office visit; Other: Evisit

• Registration Number: NCT00417456
• Lead Sponsor: Massachusetts General Hospital

Brief Summary

The purpose of this study is to test the efficacy, timeliness, and user satisfaction of an online "E-Visit" application that uses store-and-forward technology for acne patients requiring dermatologic care for their condition. Hypotheses:

1. That an "E-Visit" is an effective alternative to in-person clinic care for patients with mild to severe facial acne.

2. That providers and patients will be satisfied with this model.

3. That mean wait times for new and return visits will be reduced through the "E-Visit" model.

4. That this prototype for care will improve clinic workflow, offer additional patient access, and allow urgent cases to be seen earlier.

Detailed Description

Across the United States, a geographically mal-distributed workforce of Dermatologists exists, a problem that is projected to worsen. Patient access to dermatologic care is threatened. The dermatology workforce shortage has resulted in long wait times for patients, especially new patient visits and acute care cases.

Teledermatology has received much attention as a solution to the preceding problems. Teledermatology can reduce the burden of repeat office visits in chronic conditions by facilitating care from home. In this trial, a model incorporating store-and-forward technology is tested in general clinics while its impact on clinical outcomes, satisfaction, and wait times are studied.

Comparison: After consent, study subjects are assigned a unique study number and randomly assigned to one of two groups:

Group 1- The first group of subjects will have four (4) in-office visits spaced six weeks apart.

Group 2- The second group will have four (4) "e-visits" spaced six weeks apart.

At the end of study (after completion of 5th visit overall) all participants will complete a satisfaction survey.

Study Timeline

• Study Start: 2005-10
• Study First Submitted: 2006-12-29
• Study First Submitted QC: 2006-12-29
• Study First Posted: 2007-01-01
• Primary Completion: 2007-12
• Study Completion: 2007-12
• Status Verified: 2012-03
• Last Update Submitted: 2012-03-14
• Last Update Posted: 2012-03-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 151

Inclusion Criteria

• Age 12 or older
• Diagnosis of mild to severe facial acne
• Access to a credit card
• Access to an Internet connection and a computer
• Ability to image self
• MA Blue Cross/ Blue Shield Coverage

Exclusion Criteria

• Non-English speaking individuals
• Patients taking Accutane for their acne
• Impaired Physical ability to image self
• Impaired Cognitive ability

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
1	Office visit	Office Visits
2	Evisit	Evisit

Primary Outcome Measures

Name	Time	Method
Peer review of subject images using the Total Inflammatory Lesion Count at the end of active recruitment	6 months

Secondary Outcome Measures

Name	Time	Method
Subject satisfaction	6 months
Physician satisfaction	6 months
Timing of visits	ongoing

Trial Locations

Locations (2)

MGH Dermatology Associates; 🇺🇸 Boston, Massachusetts, United States

Brigham and Women's Hospital Department of Dermatology; 🇺🇸 Boston, Massachusetts, United States